99 related articles for article (PubMed ID: 27447565)
1. Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model.
Suman S; Das TP; Moselhy J; Pal D; Kolluru V; Alatassi H; Ankem MK; Damodaran C
Oncotarget; 2016 Aug; 7(33):53751-53761. PubMed ID: 27447565
[TBL] [Abstract][Full Text] [Related]
2. Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.
Moselhy J; Suman S; Alghamdi M; Chandarasekharan B; Das TP; Houda A; Ankem M; Damodaran C
Neoplasia; 2017 Jun; 19(6):451-459. PubMed ID: 28494348
[TBL] [Abstract][Full Text] [Related]
3. Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms.
Xing Z; Su A; Mi L; Zhang Y; He T; Qiu Y; Wei T; Li Z; Zhu J; Wu W
Drug Des Devel Ther; 2023; 17():2909-2929. PubMed ID: 37753228
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant
Kumar S; Mathew SO; Aharwal RP; Tulli HS; Mohan CD; Sethi G; Ahn KS; Webber K; Sandhu SS; Bishayee A
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259311
[TBL] [Abstract][Full Text] [Related]
5. Vimentin is required for tumor progression and metastasis in a mouse model of non-small cell lung cancer.
Berr AL; Wiese K; Dos Santos G; Koch CM; Anekalla KR; Kidd M; Davis JM; Cheng Y; Hu YS; Ridge KM
Oncogene; 2023 Jun; 42(25):2074-2087. PubMed ID: 37161053
[TBL] [Abstract][Full Text] [Related]
6. The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates.
Abeesh P; Guruvayoorappan C
Curr Mol Med; 2024; 24(4):404-418. PubMed ID: 37076466
[TBL] [Abstract][Full Text] [Related]
7.
Bhat JA; Akther T; Najar RA; Rasool F; Hamid A
Front Pharmacol; 2022; 13():1029123. PubMed ID: 36578541
[TBL] [Abstract][Full Text] [Related]
8. A Perspective on
Dubey S; Singh M; Nelson A; Karan D
J Immunol Res; 2021; 2021():9483433. PubMed ID: 34485538
[TBL] [Abstract][Full Text] [Related]
9. Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.
Cheratta AR; Thayyullathil F; Pallichankandy S; Subburayan K; Alakkal A; Galadari S
Cell Death Dis; 2021 Jan; 12(1):47. PubMed ID: 33414404
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model.
Onishi K; Miyake M; Tatsumi Y; Hori S; Nakai Y; Onishi S; Iemura Y; Owari T; Itami Y; Iida K; Anai S; Tanaka N; Shimada K; Fujimoto K
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3743-3749. PubMed ID: 33369476
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives.
Behl T; Sharma A; Sharma L; Sehgal A; Zengin G; Brata R; Fratila O; Bungau S
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33291236
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1.
Hahm ER; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1105-1115. PubMed ID: 32743846
[TBL] [Abstract][Full Text] [Related]
13.
Kim SH; Singh KB; Hahm ER; Lokeshwar BL; Singh SV
J Tradit Complement Med; 2020 May; 10(3):188-197. PubMed ID: 32670813
[TBL] [Abstract][Full Text] [Related]
14. RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells.
Kim SH; Hahm ER; Singh KB; Shiva S; Stewart-Ornstein J; Singh SV
Carcinogenesis; 2020 Jul; 41(6):778-789. PubMed ID: 32002539
[TBL] [Abstract][Full Text] [Related]
15.
Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
[TBL] [Abstract][Full Text] [Related]
16. Restoring E-cadherin Expression by Natural Compounds for Anticancer Therapies in Genital and Urinary Cancers.
Song Y; Ye M; Zhou J; Wang ZW; Zhu X
Mol Ther Oncolytics; 2019 Sep; 14():130-138. PubMed ID: 31194121
[TBL] [Abstract][Full Text] [Related]
17. Identification and Functional Characterization of Anti-metastasis and Anti-angiogenic Activities of Triethylene Glycol Derivatives.
Oh E; Garg S; Liu Y; Afzal S; Gao R; Yun CO; Kaul SC; Wadhwa R
Front Oncol; 2018; 8():552. PubMed ID: 30547009
[TBL] [Abstract][Full Text] [Related]
18. Withaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells.
Kyakulaga AH; Aqil F; Munagala R; Gupta RC
Sci Rep; 2018 Oct; 8(1):15737. PubMed ID: 30356176
[TBL] [Abstract][Full Text] [Related]
19. The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models.
Chandrasekaran B; Pal D; Kolluru V; Tyagi A; Baby B; Dahiya NR; Youssef K; Alatassi H; Ankem MK; Sharma AK; Damodaran C
Carcinogenesis; 2018 Dec; 39(12):1537-1547. PubMed ID: 30124785
[TBL] [Abstract][Full Text] [Related]
20. A crystal structure of coil 1B of vimentin in the filamentous form provides a model of a high-order assembly of a vimentin filament.
Pang AH; Obiero JM; Kulczyk AW; Sviripa VM; Tsodikov OV
FEBS J; 2018 Aug; 285(15):2888-2899. PubMed ID: 29905014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
